INKT 8-K 2026-11-12

MiNK Therapeutics, Inc. (INKT) 8-K dated 2026-11-12 — accession 0001193125-26-457244.

MiNK Therapeutics, Inc. (INKT) is a biotechnology company listed on US.

INKT: # MiNK Therapeutics Reports Third Quarter 2026 Results, First Pre-Comme…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for INKT is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The INKT SEC hub lists recent forms. The stock page is the research view.